<DOC>
	<DOCNO>NCT00899613</DOCNO>
	<brief_summary>RATIONALE : Studying level mesothelin osteopontin sample blood patient mesothelioma atypical mesothelial hyperplasia may help doctor identify biomarkers related cancer . PURPOSE : This research study look mesothelin osteopontin diagnostic marker patient mesothelioma atypical hyperplasia .</brief_summary>
	<brief_title>Mesothelin Osteopontin Diagnostic Markers Patients With Mesothelioma Atypical Mesothelial Hyperplasia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine mesothelin osteopontin serum serve early marker malignant transformation mesothelioma . Secondary - Determine cytological , histological , immunohistochemical , molecular marker precancerous disease tissue sample . - Determine SV40 carcinogenic role . - Determine relationship serum concentration mesothelin and/or osteopontin expression marker clinical progression . OUTLINE : This multicenter study . Levels mesothelin osteopontin serum ( pleural fluid , effusion present ) measure baseline 3 , 6 , 12 , 24 month . Patients mesothelioma , reactional lesion , adenocarcinoma undergo tomodensitometry ( TDM ) baseline , 3 , 6 , 12 month . Patients pleural plaque undergo TDM 12 month . Patients follow 5 year .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Inclusion criterion : Diagnosis mesothelial hyperplasia meeting 1 follow criterion : Confirmed prior exposure asbestos presence pleural effusion meet 1 follow diagnostic criterion : Mesothelioma Mesothelial hyperplasia unspecified malignancy Reactional inflammatory hyperplasia No asbestos exposure pleural effusion pleural malignant mesothelioma pulmonary metastasis Prior exposure asbestos , pleural effusion , asymptomatic ( pleural plaque present ) No prior exposure asbestos benign pleural effusion Tissue obtain pleuroscopy , surgical biopsy , videothoracoscopy available Paraffinembedded frozen tissue available Exclusion criterion : Solitary fibrous tumor Diffuse pleural fibrosis Purulent pleurisy PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : No prior chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>localize malignant mesothelioma</keyword>
	<keyword>lung metastasis</keyword>
	<keyword>malignant pleural effusion</keyword>
</DOC>